Amicus Therapeutics Inc. buy Wells Fargo & Company
Start price
30.05.24
/
50%
€8.90
Target price
30.05.25
€16.62
Performance (%)
-39.89%
End price
31.05.25
€5.35
Summary
This prediction ended on 31.05.25 with a price of €5.35. The BUY prediction by Wells_Fargo___Compan for Amicus Therapeutics Inc. performed very badly with a performance of -39.89%. Wells_Fargo___Compan has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | 0.833% | 0.833% | 39.884% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $18.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.70
20.02.25
20.02.25
€16.27
20.02.26
20.02.26
39.08%
13.01.26
13.01.26
